TEL AVIV, Israel--(BUSINESS WIRE)--InspireMD, Ltd. announced today it has launched MGuardTM Coronary Stent in the Italian market. MGuardTM has received last October CE Mark approval to treat patients with coronary artery diseases. Distribution of MGuardTM in Italy will be carried out by InspireMD representative in Italy – Kardia, based in Milan.
